I think the only reason it's not trading is because the ask

New Post Public Reply Private Reply Replies (2) Message Board
Sully79 rwh01 #26354
411
I think the only reason it's not trading is because the ask is 175 dollars, and the bid is 15. Not sure though. If something was halted, I'm guessing there wouldn't be a bid and ask, or am I wrong?

Andiamo Corp (ANDI) Stock Research Links

ANDI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 8

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading

Top 5 Most Recently Viewed Articles

OSB Group PLC Updates: Share Buyback and Voting Rights Explained

Updated Category News Views 212

OSB Group PLC Announces Share Buyback Execution OSB GROUP PLC is actively engaging in a strategic initiative as part of its ongoing share buyback programme. Each decision made by the company signifies their commitment to enhancing shareholder value, demonstrating a proactive approach in managing their capital structure. Details of the Share Buyback Programme Recently, OSB...

Continue Reading
Adlai Nortye to Showcase Innovative Cancer Therapy at Key Conference

Updated Category News Views 179

Adlai Nortye's Participation in an International Conference Adlai Nortye Ltd. (NASDAQ: ANL), a forward-thinking biotechnology firm dedicated to pioneering cancer therapies, has announced its participation in a prestigious international conference focused on molecular targets and cancer treatments. This significant event will take place in Boston from October 22-26 in...

Continue Reading
Acumatica's AI Innovations Transform Business Operations

Updated Category News Views 126

Acumatica's AI Innovations Transform Business Operations During an inspiring keynote at a recent summit, Acumatica showcased its commitment to revolutionizing business operations with an AI-first product strategy. This innovative approach aims to significantly enhance how small and mid-sized businesses operate, addressing the real-world challenges they face. With advanced...

Continue Reading
Gabelli Funds' Special Symposium to Highlight Industry Trends

Updated Category News Views 129

Gabelli Funds Hosts 16th Annual Specialty Chemicals Symposium Gabelli Funds is excited to announce its 16th Annual Specialty Chemicals Symposium, which will be held at The Harvard Club. This year's event promises to offer valuable insights into a variety of topics that are crucial to industry stakeholders. Key Focus Areas With the evolving landscape of the specialty...

Continue Reading
THEON Expands Military Clientele with New IRIS-C Orders

Updated Category News Views 161

New Orders for THEON’s Thermal Clip-On Technology THEON International Plc has recently received an exciting new order from a military client in Northern Europe for its thermal clip-on units, known as IRIS-C. This marks a significant development as these units are designed specifically to enhance the capabilities of Special Forces. Following extensive testing, the client...

Continue Reading